Sanofi's 4-in-1 influenza vaccine joins GlaxoSmithKline's Fluarix Quadrivalent and AstraZeneca's MedImmune FluMist Quadrivalent that are already approved for use in the United States. Related news: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback